Magnolia NeuroSciences Company
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Investors
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2018
Employees Number:
1-10
Funding Status:
N/A
Estimated Revenue:
Less than $1M
Register and Claim Ownership